LENZ Therapeutics (Formerly Graphite Bio) Files 8-K
Ticker: LENZ · Form: 8-K · Filed: Jul 31, 2025 · CIK: 1815776
| Field | Detail |
|---|---|
| Company | Lenz Therapeutics, Inc. (LENZ) |
| Form Type | 8-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-history, filing-update
TL;DR
LENZ Therapeutics, formerly Graphite Bio, filed an 8-K on 7/31/25, confirming its identity and history.
AI Summary
On July 31, 2025, LENZ Therapeutics, Inc. filed an 8-K report. The filing indicates the company's former names were Graphite Bio, Inc. and Integral Medicines, Inc., with name changes occurring on March 12, 2021, and June 22, 2020, respectively. The report details the company's incorporation in Delaware and provides its principal executive office address in Solana Beach, California.
Why It Matters
This filing provides historical corporate identity information for LENZ Therapeutics, Inc., which may be relevant for investors tracking the company's evolution and previous entities.
Risk Assessment
Risk Level: low — The filing is primarily informational, detailing corporate history and addresses, and does not contain new financial or operational risks.
Key Players & Entities
- LENZ Therapeutics, Inc. (company) — Registrant
- Graphite Bio, Inc. (company) — Former company name
- Integral Medicines, Inc. (company) — Former company name
- July 31, 2025 (date) — Date of report
- 201 Lomas Santa Fe Drive, Suite 300 (address) — Principal executive offices
- Solana Beach, California (location) — Principal executive offices location
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is LENZ Therapeutics, Inc.
In which jurisdiction was LENZ Therapeutics, Inc. incorporated?
LENZ Therapeutics, Inc. was incorporated in Delaware.
What is the Commission File Number for LENZ Therapeutics, Inc.?
The Commission File Number for LENZ Therapeutics, Inc. is 001-40532.
When did LENZ Therapeutics, Inc. change its name from Graphite Bio, Inc.?
The company changed its name from Graphite Bio, Inc. on March 12, 2021.
What is the address of LENZ Therapeutics, Inc.'s principal executive offices?
The address of LENZ Therapeutics, Inc.'s principal executive offices is 201 Lomas Santa Fe Dr., Suite 300, Solana Beach, California 92075.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 31, 2025 regarding LENZ Therapeutics, Inc. (LENZ).